Impact on hospital mortality of catheter removal and adequate antifungal therapy in Candida spp. bloodstream infections (Q44830700)

6 December 2017

title

Impact on hospital mortality of catheter removal and adequate antifungal therapy in Candida spp. bloodstream infections (English)

1 reference

6 December 2017

author

Emilio García-Cabrera

object named as

Emilio García-Cabrera

3

0 references

Jose Garnacho-Montero

object named as

José Garnacho-Montero

1

0 references

author name string

Ana Díaz-Martín

2

1 reference

6 December 2017

Maite Ruiz Pérez de Pipaón

4

1 reference

6 December 2017

Clara Hernández-Caballero

5

1 reference

6 December 2017

José A Lepe-Jiménez

6

1 reference

6 December 2017

language of work or name

English

0 references

publication date

3 September 2012

1 reference

Journal of Antimicrobial Chemotherapy

6 December 2017

published in

1 reference

6 December 2017

volume

68

1 reference

6 December 2017

issue

1

1 reference

6 December 2017

page(s)

206-213

1 reference

Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study

6 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKS347

Septic shock: an analysis of outcomes for patients with onset on hospital wards versus intensive care units.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKS347

Impact of early central venous catheter removal on outcome in patients with candidaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKS347

Epidemiology and predictors of mortality in cases of Candida bloodstream infection: results from population-based surveillance, barcelona, Spain, from 2002 to 2003.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKS347

Delaying the empiric treatment of candida bloodstream infection until positive blood culture results are obtained: a potential risk factor for hospital mortality

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKS347

Adequacy of empirical antifungal therapy and effect on outcome among patients with invasive Candida species infections.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKS347

Prospective observational study of candidemia in São Paulo, Brazil: incidence rate, epidemiology, and predictors of mortality.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKS347

Determinants of mortality in non-neutropenic ICU patients with candidaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKS347

The impact of delaying the initiation of appropriate antifungal treatment for Candida bloodstream infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKS347

Timing of susceptibility-based antifungal drug administration in patients with Candida bloodstream infection: correlation with outcomes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKS347

APACHE II: a severity of disease classification system

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKS347

Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKS347

Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of America.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKS347

An official American Thoracic Society statement: Treatment of fungal infections in adult pulmonary and critical care patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKS347

Comparison of caspofungin and amphotericin B for invasive candidiasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKS347

Anidulafungin versus fluconazole for invasive candidiasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKS347

Should vascular catheters be removed from all patients with candidemia? An evidence-based review

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKS347

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKS347

Impact of treatment strategy on outcomes in patients with candidemia and other forms of invasive candidiasis: a patient-level quantitative review of randomized trials.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKS347

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKS347

Clinical factors associated with fluconazole resistance and short-term survival in patients with Candida bloodstream infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKS347

Improving survival of patients with candidaemia: analysis of prognostic factors from a long-term, nationwide study in Iceland

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKS347

Management of central venous catheters in patients with cancer and candidemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKS347

A multicentre study of antifungal strategies and outcome of Candida spp. peritonitis in intensive-care units

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKS347

Early prediction of Candida glabrata fungemia in nonneutropenic critically ill patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKS347

Septic shock attributed to Candida infection: importance of empiric therapy and source control

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKS347

Early Removal of Central Venous Catheter in Patients with Candidemia Does Not Improve Outcome: Analysis of 842 Patients from 2 Randomized Clinical Trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKS347

Micafungin versus liposomal amphotericin B for candidaemia and invasive candidosis: a phase III randomised double-blind trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKS347

Incidence, risk factors, and predictors of outcome of candidemia. Survey in 2 Italian university hospitals

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKS347

21 January 2018

Identifiers

DOI

10.1093/JAC/DKS347

1 reference

6 December 2017

1 reference